MDCO-216 - Novartis
The Medicines Company: Goldman Sachs Global Healthcare Conference (The Medicines Company Press Release) - Jun 12, 2013 - Anticipated initiation of P1 trial for acute coronary syndrome in H2 2013 
Anticipated trial initiation date Acute Coronary Syndrome
http://seekingalpha.com/article/1495662-the-medicines-company-s-ceo-presents-at-goldman-sachs-34th-annual-global-healthcare-conference-transcript?part=single
 
Jun 12, 2013
 
.